Digital healthcare as a solution for global challenges: A call for action

IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY
Mireille N. Bekker, Olof Stephansson, Nerea Maiz, Michèle van der Kemp, Kees Ahaus, Arie Franx
{"title":"Digital healthcare as a solution for global challenges: A call for action","authors":"Mireille N. Bekker,&nbsp;Olof Stephansson,&nbsp;Nerea Maiz,&nbsp;Michèle van der Kemp,&nbsp;Kees Ahaus,&nbsp;Arie Franx","doi":"10.1111/aogs.15066","DOIUrl":null,"url":null,"abstract":"<p>In an era of rising technological advancements, healthcare systems worldwide are facing a coincidence of challenges: a growing shortage of healthcare professionals, unsustainable growth of the costs of care, and an alarming rise in chronic conditions. The global healthcare workforce is stretched to its limits, with the World Health Organization (WHO) projecting a shortfall of 10 million healthcare workers by 2030.<span><sup>1</sup></span> Compounding this crisis are aging populations and the rising prevalence of chronic conditions, such as diabetes and cardiovascular diseases. The global economic burden of diabetes alone is expected to surpass $845 billion annually by 2045.<span><sup>2</sup></span></p><p>These pressures demand innovative solutions. Digital health care—enabled by, for example, telemonitoring, artificial intelligence, and remote care platforms—emerges as a promising response. However, despite its potential to revolutionize care delivery, its implementation remains scarce. Research is urgently needed to validate its safety, efficacy, and cost-effectiveness, ensuring sustainable integration into healthcare systems.</p><p>Digital home healthcare can alleviate system burdens by replacing hospital visits and/or admissions, enabling continuous monitoring, early detection of complications, and personalized care tailored to the individual patient's needs. For patients, digital home healthcare offers convenience, reduces the need for hospital visits, and empowers them to manage their health. Providers benefit from real-time data, enabling proactive interventions and efficient resource allocation.</p><p>Premature adoption of digital home healthcare without robust evidence carries significant risks. Poorly designed systems may exacerbate health disparities, particularly for patients with limited digital access. Overdiagnosis and overtreatment could lead to unnecessary anxiety, medical interventions, additional strain for healthcare workers, and inflated costs. A cautious, evidence-based approach is essential to ensure digital solutions deliver on their promise of safer, more efficient care.</p><p>Research plays a pivotal role in overcoming these barriers. Well-designed studies are needed to confirm the safety, efficacy, and scalability of digital health solutions across diverse populations. Assessing cost-effectiveness is equally crucial to designing sustainable funding models. Value-based reimbursement—rewarding outcomes rather than service volume—offers a promising framework for digital home healthcare. Furthermore, understanding both practical and psychological barriers and facilitators of systemic adoption is critical for scaling digital solutions. Research can identify best practices for integrating digital tools into existing workflows and addressing resistance among providers and patients.</p><p>There are about 4 million childbirths in Europe every year,<span><sup>3</sup></span> and globally about 140 million.<span><sup>4</sup></span> Several pregnancy complications may compromise maternal or fetal health and turn a pregnancy from low-risk into high-risk. Currently, around 10% of pregnancies across the EU are considered high-risk, and this number is increasing.<span><sup>5</sup></span> Hypertensive disorders of pregnancy (HDP) result in maternal complications but also affect fetal outcomes, including fetal growth restriction leading to low birth weight and preterm birth. These complications are associated with increased risk for maternal and perinatal mortality and with long-term health implications and psychological effects for the mother, child, and their family.</p><p>To this day, many high-risk pregnancies need hospitalization or a steep rise in outpatient clinic visits, usually extending through (pre-term) delivery into the postpartum period. These care activities deeply impact patient experience and quality of life for the patient and their families, as well as increasing both healthcare costs and clinical workload. Even so, pregnant women seem to be the ideal population for remote digital care as they are relatively young, used to organizing their lives with their smartphone, and due to the work-family life benefit, extra from restraining from hospital visits.</p><p>Several studies in pregnant women have shown the benefits from home monitoring of symptoms and blood pressure at home using remote blood pressure devices, supported by an online platform.<span><sup>6-9</sup></span> In the BUMP-2 trial, 430 women with HDP in a self-monitoring group were compared with 420 women receiving usual care.<span><sup>6</sup></span> No significant differences in perinatal outcomes were found, confirming the safety of home monitoring. Several other studies confirmed feasibility and safety. The SAFE@home case–control study showed that blood pressure telemonitoring for women at risk of hypertensive complications allows fewer antenatal visits and hypertension-related admissions, accompanied by a 19.7% net reduction in costs. Home monitoring was appreciated by patients with similar clinical outcomes.<span><sup>8, 9</sup></span></p><p>The next step is home monitoring of the pregnant woman and her fetus in case of pregnancy complications often requiring hospital admission in preeclampsia, premature rupture of membranes, and fetal growth restriction. The fetal condition can be assessed using remote CTG devices tracing the fetal heart rate. In the HoTeL study, patients were randomized between home monitoring of fetal–maternal condition and hospital admission.<span><sup>10</sup></span> During home monitoring, daily assessment of the remote CTG and maternal parameters was performed by clinical midwives. In case of alarm symptoms, the midwife referred the patient to the hospital. It was a requirement that the patient lived within a 30-minute travel distance from a hospital. The study showed improved patient satisfaction, an 18% net cost reduction with equivalent clinical safety compared to traditional hospital care. In this study with a non-inferiority design, the home-monitoring group did not show inferior outcomes than the hospital group. While this randomized study showed promising results, more data are needed on the clinical safety of telemonitoring pregnancies. Moreover, knowledge is needed on how to overcome challenges impeding the implementation of remote digital pregnancy care for large-scale uptake throughout the globe. In the meantime, tight safety arrangements are necessary for the use of digital technology.</p><p>The time to act is now. Healthcare systems cannot afford to overlook the potential of digital home healthcare in addressing workforce shortages and rising costs. Governments and funding agencies must prioritize research into digital home healthcare, supporting clinical trials, economic evaluations, and implementation studies. Stakeholders should collaborate to create reimbursement frameworks that align incentives with outcomes and support the widespread adoption of digital health solutions. Also, technological support for the connection of remote devices and platforms to electronic medical records is crucial.</p><p>International collaboration in consortia may address challenges unique to different healthcare systems. By pooling expertise and resources, such initiatives can develop adaptable solutions for diverse healthcare settings. We have established the PregnaDigit-EU consortium to enhance the potential of digital remote pregnancy care. PregnaDigit-EU focuses on remote digital pregnancy care to monitor high-risk pregnancies using advanced home-monitoring devices, such as cardiotocography (CTG) for fetal health and blood pressure monitors for maternal health. By comparing clinical and implementation outcomes, patients' needs as well as reimbursement challenges between three European countries (the Netherlands, Sweden, and Spain) we aim to assess barriers and improve digital solutions for different populations.</p><p>Digital home healthcare holds immense promise in addressing the global challenges confronting healthcare systems. By enabling safe, effective, and patient-centered care, it has the potential to transform care delivery. However, its successful implementation hinges on robust scientific evidence, sustainable funding models, and a deep understanding of diverse contexts.</p><p>The PregnaDigit-EU project aims to offer a blueprint for the future of digital healthcare, demonstrating how research and innovation can overcome barriers to adoption. With concerted efforts and a strong commitment to collaboration, we hopefully help to unlock the full potential of digital home healthcare, paving the way for more accessible, sustainable, and equitable healthcare systems.</p>","PeriodicalId":6990,"journal":{"name":"Acta Obstetricia et Gynecologica Scandinavica","volume":"104 2","pages":"250-252"},"PeriodicalIF":3.5000,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11782081/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Obstetricia et Gynecologica Scandinavica","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/aogs.15066","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

In an era of rising technological advancements, healthcare systems worldwide are facing a coincidence of challenges: a growing shortage of healthcare professionals, unsustainable growth of the costs of care, and an alarming rise in chronic conditions. The global healthcare workforce is stretched to its limits, with the World Health Organization (WHO) projecting a shortfall of 10 million healthcare workers by 2030.1 Compounding this crisis are aging populations and the rising prevalence of chronic conditions, such as diabetes and cardiovascular diseases. The global economic burden of diabetes alone is expected to surpass $845 billion annually by 2045.2

These pressures demand innovative solutions. Digital health care—enabled by, for example, telemonitoring, artificial intelligence, and remote care platforms—emerges as a promising response. However, despite its potential to revolutionize care delivery, its implementation remains scarce. Research is urgently needed to validate its safety, efficacy, and cost-effectiveness, ensuring sustainable integration into healthcare systems.

Digital home healthcare can alleviate system burdens by replacing hospital visits and/or admissions, enabling continuous monitoring, early detection of complications, and personalized care tailored to the individual patient's needs. For patients, digital home healthcare offers convenience, reduces the need for hospital visits, and empowers them to manage their health. Providers benefit from real-time data, enabling proactive interventions and efficient resource allocation.

Premature adoption of digital home healthcare without robust evidence carries significant risks. Poorly designed systems may exacerbate health disparities, particularly for patients with limited digital access. Overdiagnosis and overtreatment could lead to unnecessary anxiety, medical interventions, additional strain for healthcare workers, and inflated costs. A cautious, evidence-based approach is essential to ensure digital solutions deliver on their promise of safer, more efficient care.

Research plays a pivotal role in overcoming these barriers. Well-designed studies are needed to confirm the safety, efficacy, and scalability of digital health solutions across diverse populations. Assessing cost-effectiveness is equally crucial to designing sustainable funding models. Value-based reimbursement—rewarding outcomes rather than service volume—offers a promising framework for digital home healthcare. Furthermore, understanding both practical and psychological barriers and facilitators of systemic adoption is critical for scaling digital solutions. Research can identify best practices for integrating digital tools into existing workflows and addressing resistance among providers and patients.

There are about 4 million childbirths in Europe every year,3 and globally about 140 million.4 Several pregnancy complications may compromise maternal or fetal health and turn a pregnancy from low-risk into high-risk. Currently, around 10% of pregnancies across the EU are considered high-risk, and this number is increasing.5 Hypertensive disorders of pregnancy (HDP) result in maternal complications but also affect fetal outcomes, including fetal growth restriction leading to low birth weight and preterm birth. These complications are associated with increased risk for maternal and perinatal mortality and with long-term health implications and psychological effects for the mother, child, and their family.

To this day, many high-risk pregnancies need hospitalization or a steep rise in outpatient clinic visits, usually extending through (pre-term) delivery into the postpartum period. These care activities deeply impact patient experience and quality of life for the patient and their families, as well as increasing both healthcare costs and clinical workload. Even so, pregnant women seem to be the ideal population for remote digital care as they are relatively young, used to organizing their lives with their smartphone, and due to the work-family life benefit, extra from restraining from hospital visits.

Several studies in pregnant women have shown the benefits from home monitoring of symptoms and blood pressure at home using remote blood pressure devices, supported by an online platform.6-9 In the BUMP-2 trial, 430 women with HDP in a self-monitoring group were compared with 420 women receiving usual care.6 No significant differences in perinatal outcomes were found, confirming the safety of home monitoring. Several other studies confirmed feasibility and safety. The SAFE@home case–control study showed that blood pressure telemonitoring for women at risk of hypertensive complications allows fewer antenatal visits and hypertension-related admissions, accompanied by a 19.7% net reduction in costs. Home monitoring was appreciated by patients with similar clinical outcomes.8, 9

The next step is home monitoring of the pregnant woman and her fetus in case of pregnancy complications often requiring hospital admission in preeclampsia, premature rupture of membranes, and fetal growth restriction. The fetal condition can be assessed using remote CTG devices tracing the fetal heart rate. In the HoTeL study, patients were randomized between home monitoring of fetal–maternal condition and hospital admission.10 During home monitoring, daily assessment of the remote CTG and maternal parameters was performed by clinical midwives. In case of alarm symptoms, the midwife referred the patient to the hospital. It was a requirement that the patient lived within a 30-minute travel distance from a hospital. The study showed improved patient satisfaction, an 18% net cost reduction with equivalent clinical safety compared to traditional hospital care. In this study with a non-inferiority design, the home-monitoring group did not show inferior outcomes than the hospital group. While this randomized study showed promising results, more data are needed on the clinical safety of telemonitoring pregnancies. Moreover, knowledge is needed on how to overcome challenges impeding the implementation of remote digital pregnancy care for large-scale uptake throughout the globe. In the meantime, tight safety arrangements are necessary for the use of digital technology.

The time to act is now. Healthcare systems cannot afford to overlook the potential of digital home healthcare in addressing workforce shortages and rising costs. Governments and funding agencies must prioritize research into digital home healthcare, supporting clinical trials, economic evaluations, and implementation studies. Stakeholders should collaborate to create reimbursement frameworks that align incentives with outcomes and support the widespread adoption of digital health solutions. Also, technological support for the connection of remote devices and platforms to electronic medical records is crucial.

International collaboration in consortia may address challenges unique to different healthcare systems. By pooling expertise and resources, such initiatives can develop adaptable solutions for diverse healthcare settings. We have established the PregnaDigit-EU consortium to enhance the potential of digital remote pregnancy care. PregnaDigit-EU focuses on remote digital pregnancy care to monitor high-risk pregnancies using advanced home-monitoring devices, such as cardiotocography (CTG) for fetal health and blood pressure monitors for maternal health. By comparing clinical and implementation outcomes, patients' needs as well as reimbursement challenges between three European countries (the Netherlands, Sweden, and Spain) we aim to assess barriers and improve digital solutions for different populations.

Digital home healthcare holds immense promise in addressing the global challenges confronting healthcare systems. By enabling safe, effective, and patient-centered care, it has the potential to transform care delivery. However, its successful implementation hinges on robust scientific evidence, sustainable funding models, and a deep understanding of diverse contexts.

The PregnaDigit-EU project aims to offer a blueprint for the future of digital healthcare, demonstrating how research and innovation can overcome barriers to adoption. With concerted efforts and a strong commitment to collaboration, we hopefully help to unlock the full potential of digital home healthcare, paving the way for more accessible, sustainable, and equitable healthcare systems.

数字医疗作为应对全球挑战的解决方案:行动呼吁。
在技术不断进步的时代,世界各地的卫生保健系统正面临着一系列挑战:卫生保健专业人员日益短缺,医疗费用不可持续增长,慢性病发病率惊人上升。全球卫生保健人力已达到极限,世界卫生组织(世卫组织)预计,到2030年,卫生保健工作者缺口将达到1000万。使这一危机更加严重的是人口老龄化以及糖尿病和心血管疾病等慢性病的日益流行。预计到20452年,仅糖尿病一项全球经济负担每年就将超过8450亿美元。这些压力需要创新的解决方案。数字医疗——例如,由远程监控、人工智能和远程护理平台支持——作为一种有希望的回应出现了。然而,尽管它有可能彻底改变医疗服务,但它的实施仍然很少。迫切需要研究来验证其安全性、有效性和成本效益,确保可持续地整合到医疗保健系统中。数字家庭医疗保健可以通过取代医院就诊和/或住院、实现持续监测、早期发现并发症以及根据患者个人需求量身定制的个性化护理来减轻系统负担。对于患者来说,数字家庭医疗保健提供了便利,减少了医院就诊的需要,并使他们能够管理自己的健康。供应商可以从实时数据中受益,从而实现主动干预和有效的资源分配。在没有有力证据的情况下过早采用数字家庭医疗保健会带来重大风险。设计不良的系统可能会加剧健康差距,特别是对于数字访问有限的患者。过度诊断和过度治疗可能导致不必要的焦虑、医疗干预、医护人员的额外压力和成本膨胀。要确保数字解决方案兑现其提供更安全、更高效护理的承诺,必须采取谨慎、循证的方法。研究在克服这些障碍方面起着关键作用。需要精心设计的研究来确认数字健康解决方案在不同人群中的安全性、有效性和可扩展性。评估成本效益对设计可持续筹资模式同样至关重要。基于价值的补偿——奖励结果而不是服务量——为数字家庭医疗保健提供了一个很有前景的框架。此外,了解系统采用的实际和心理障碍以及促进因素对于扩展数字解决方案至关重要。研究可以确定将数字工具集成到现有工作流程中的最佳实践,并解决提供者和患者之间的阻力。欧洲每年约有400万新生儿,全球约为1.4亿一些妊娠并发症可能危及母体或胎儿健康,使妊娠从低风险变为高风险。目前,整个欧盟约有10%的怀孕被认为是高风险的,而且这个数字还在增加妊娠期高血压疾病(HDP)可导致产妇并发症,但也会影响胎儿结局,包括胎儿生长受限导致低出生体重和早产。这些并发症与孕产妇和围产期死亡风险增加有关,并对母亲、儿童及其家庭产生长期健康影响和心理影响。直到今天,许多高危妊娠需要住院治疗或门诊就诊的急剧增加,通常从(早产)分娩延伸到产后。这些护理活动对患者体验和患者及其家属的生活质量产生了深远的影响,同时也增加了医疗成本和临床工作量。即便如此,孕妇似乎是远程数字医疗的理想人群,因为她们相对年轻,习惯于用智能手机组织自己的生活,而且由于工作和家庭生活的好处,另外还可以避免去医院。几项针对孕妇的研究表明,使用在线平台支持的远程血压设备在家监测症状和血压是有益的。在BUMP-2试验中,430名HDP妇女在自我监测组与420名接受常规护理的妇女进行比较围产儿结局无显著差异,证实了家庭监测的安全性。其他几项研究也证实了这种方法的可行性和安全性。SAFE@home病例对照研究表明,对有高血压并发症风险的妇女进行血压远程监测可以减少产前检查和高血压相关入院,同时成本净降低19.7%。家庭监测受到临床结果相似的患者的欢迎。 8,9下一步是对孕妇和胎儿进行家庭监测,以防出现妊娠并发症,如先兆子痫、胎膜早破和胎儿生长受限等,通常需要住院。胎儿状况可以通过远程CTG装置跟踪胎儿心率来评估。在HoTeL研究中,患者被随机分为在家监测胎母状况和住院两组在家庭监测期间,由临床助产士进行远程CTG和产妇参数的日常评估。如果出现惊恐症状,助产士就把病人转到医院。这是一个要求,病人住在离医院30分钟车程的范围内。研究表明,与传统医院护理相比,患者满意度提高,净成本降低18%,临床安全性相当。在这项非劣效性设计的研究中,家庭监护组的结果并不比医院组差。虽然这项随机研究显示了有希望的结果,但需要更多的数据来证明远程监测妊娠的临床安全性。此外,还需要了解如何克服阻碍在全球范围内大规模实施远程数字妊娠护理的挑战。与此同时,严格的安全安排对数字技术的使用是必要的。现在是行动的时候了。医疗保健系统不能忽视数字家庭医疗保健在解决劳动力短缺和成本上升方面的潜力。政府和资助机构必须优先考虑数字家庭医疗保健的研究,支持临床试验、经济评估和实施研究。利益攸关方应合作创建报销框架,使激励措施与成果相一致,并支持广泛采用数字卫生解决方案。此外,为远程设备和平台与电子医疗记录的连接提供技术支持也至关重要。联盟中的国际合作可以解决不同医疗保健系统所特有的挑战。通过汇集专业知识和资源,这些举措可以针对不同的医疗保健环境开发适应性强的解决方案。我们已经建立了PregnaDigit-EU联盟,以增强数字远程妊娠护理的潜力。妊娠数字-欧盟侧重于远程数字妊娠护理,利用先进的家庭监测设备监测高危妊娠,如用于胎儿健康的心脏造影(CTG)和用于孕产妇健康的血压监测仪。通过比较三个欧洲国家(荷兰、瑞典和西班牙)的临床和实施结果、患者需求以及报销挑战,我们旨在评估障碍并改进针对不同人群的数字解决方案。数字家庭医疗在解决医疗系统面临的全球挑战方面具有巨大的前景。通过实现安全、有效和以患者为中心的护理,它有可能改变医疗服务。然而,它的成功实施取决于强有力的科学证据、可持续的筹资模式以及对不同背景的深刻理解。欧盟妊娠数字化项目旨在为数字医疗的未来提供蓝图,展示研究和创新如何克服采用障碍。通过共同努力和对合作的坚定承诺,我们希望帮助释放数字家庭医疗保健的全部潜力,为更容易获得、可持续和公平的医疗保健系统铺平道路。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
8.00
自引率
4.70%
发文量
180
审稿时长
3-6 weeks
期刊介绍: Published monthly, Acta Obstetricia et Gynecologica Scandinavica is an international journal dedicated to providing the very latest information on the results of both clinical, basic and translational research work related to all aspects of women’s health from around the globe. The journal regularly publishes commentaries, reviews, and original articles on a wide variety of topics including: gynecology, pregnancy, birth, female urology, gynecologic oncology, fertility and reproductive biology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信